Prostate Cancer
Study on the Impact of Hormone Therapy for Prostate Cancer on the Quality of Life and the Psycho-Relational Sphere of Patients: ProQoL.
November 14, 2024
An Autophagy-Targeting Chimera Induces Degradation of Androgen Receptor Mutants and AR-v7 in Castration-Resistant Prostate Cancer.
November 14, 2024
Repeatability of quantitative MR fingerprinting for T1 and T2 measurements of metastatic bone in prostate cancer patients.
November 13, 2024
Tumor regression after neoadjuvant hormonal therapy in high risk prostate cancer: pathological outcomes from a randomized phase II trial.
November 13, 2024
Use of Placebo in Urologic Oncology Randomized Controlled Trials.
November 13, 2024
Update on PSMA-based Prostate Cancer Imaging.
November 13, 2024
Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer: Final Results from the Prospective, Single-arm, Phase 2 MEDCARE Trial.
November 13, 2024
Multi-task Bayesian model combining FDG-PET/CT imaging and clinical data for interpretable high-grade prostate cancer prognosis.
November 12, 2024
Patients' anxieties and fears: a comparison between transrectal prostate biopsy and prostate MRI.
November 12, 2024
Prostate cancer theragnostics biomarkers: An update.
November 12, 2024